PL2714926T3 - Biomarkery raka płuca - Google Patents
Biomarkery raka płucaInfo
- Publication number
- PL2714926T3 PL2714926T3 PL12723210T PL12723210T PL2714926T3 PL 2714926 T3 PL2714926 T3 PL 2714926T3 PL 12723210 T PL12723210 T PL 12723210T PL 12723210 T PL12723210 T PL 12723210T PL 2714926 T3 PL2714926 T3 PL 2714926T3
- Authority
- PL
- Poland
- Prior art keywords
- biomarkers
- lung cancer
- lung
- cancer
- Prior art date
Links
- 206010058467 Lung neoplasm malignant Diseases 0.000 title 1
- 239000000090 biomarker Substances 0.000 title 1
- 201000005202 lung cancer Diseases 0.000 title 1
- 208000020816 lung neoplasm Diseases 0.000 title 1
Classifications
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
- G01N33/574—Immunoassay; Biospecific binding assay; Materials therefor for cancer
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
- C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
- C12Q1/6876—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes
- C12Q1/6883—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material
- C12Q1/6886—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material for cancer
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/09—Recombinant DNA-technology
- C12N15/11—DNA or RNA fragments; Modified forms thereof; Non-coding nucleic acids having a biological activity
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
- C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q2600/00—Oligonucleotides characterized by their use
- C12Q2600/112—Disease subtyping, staging or classification
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q2600/00—Oligonucleotides characterized by their use
- C12Q2600/118—Prognosis of disease development
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q2600/00—Oligonucleotides characterized by their use
- C12Q2600/158—Expression markers
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Engineering & Computer Science (AREA)
- Organic Chemistry (AREA)
- Immunology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Genetics & Genomics (AREA)
- Zoology (AREA)
- Wood Science & Technology (AREA)
- Molecular Biology (AREA)
- Analytical Chemistry (AREA)
- Pathology (AREA)
- Biotechnology (AREA)
- Biochemistry (AREA)
- Physics & Mathematics (AREA)
- Microbiology (AREA)
- General Health & Medical Sciences (AREA)
- Biomedical Technology (AREA)
- General Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Biophysics (AREA)
- Hospice & Palliative Care (AREA)
- Oncology (AREA)
- Urology & Nephrology (AREA)
- Hematology (AREA)
- Medicinal Chemistry (AREA)
- Food Science & Technology (AREA)
- Cell Biology (AREA)
- General Physics & Mathematics (AREA)
- Plant Pathology (AREA)
- Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
- Investigating Or Analysing Biological Materials (AREA)
- Medicinal Preparation (AREA)
- Apparatus For Radiation Diagnosis (AREA)
- Apparatus Associated With Microorganisms And Enzymes (AREA)
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201161490021P | 2011-05-25 | 2011-05-25 | |
| EP12723210.6A EP2714926B1 (en) | 2011-05-25 | 2012-05-24 | Biomarkers for lung cancer |
| PCT/EP2012/059784 WO2012160177A1 (en) | 2011-05-25 | 2012-05-24 | Biomarkers for lung cancer |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| PL2714926T3 true PL2714926T3 (pl) | 2015-12-31 |
Family
ID=46148889
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| PL12723210T PL2714926T3 (pl) | 2011-05-25 | 2012-05-24 | Biomarkery raka płuca |
Country Status (16)
| Country | Link |
|---|---|
| US (1) | US20140227372A1 (pl) |
| EP (1) | EP2714926B1 (pl) |
| JP (1) | JP2014516531A (pl) |
| KR (1) | KR20140024907A (pl) |
| CN (1) | CN103562409B (pl) |
| AU (1) | AU2012260785B2 (pl) |
| BR (1) | BR112013029787A2 (pl) |
| CA (1) | CA2836844A1 (pl) |
| ES (1) | ES2550192T3 (pl) |
| IL (1) | IL229319A0 (pl) |
| MX (1) | MX340453B (pl) |
| PL (1) | PL2714926T3 (pl) |
| PT (1) | PT2714926E (pl) |
| RU (1) | RU2013157589A (pl) |
| SG (1) | SG194615A1 (pl) |
| WO (1) | WO2012160177A1 (pl) |
Families Citing this family (30)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US8822663B2 (en) | 2010-08-06 | 2014-09-02 | Moderna Therapeutics, Inc. | Engineered nucleic acids and methods of use thereof |
| CA2821992A1 (en) | 2010-10-01 | 2012-04-05 | Moderna Therapeutics, Inc. | Engineered nucleic acids and methods of use thereof |
| DE12722942T1 (de) | 2011-03-31 | 2021-09-30 | Modernatx, Inc. | Freisetzung und formulierung von manipulierten nukleinsäuren |
| US9464124B2 (en) | 2011-09-12 | 2016-10-11 | Moderna Therapeutics, Inc. | Engineered nucleic acids and methods of use thereof |
| HRP20220250T1 (hr) | 2011-10-03 | 2022-04-29 | Modernatx, Inc. | Modificirani nukleozidi, nukleotidi i nukleinske kiseline, te njihove uporabe |
| SI2791160T1 (sl) | 2011-12-16 | 2022-07-29 | Modernatx, Inc. | Sestave modificirane MRNA |
| US9572897B2 (en) | 2012-04-02 | 2017-02-21 | Modernatx, Inc. | Modified polynucleotides for the production of cytoplasmic and cytoskeletal proteins |
| US10501512B2 (en) | 2012-04-02 | 2019-12-10 | Modernatx, Inc. | Modified polynucleotides |
| AU2013243952A1 (en) | 2012-04-02 | 2014-10-30 | Modernatx, Inc. | Modified polynucleotides for the production of cytoplasmic and cytoskeletal proteins |
| US9283287B2 (en) | 2012-04-02 | 2016-03-15 | Moderna Therapeutics, Inc. | Modified polynucleotides for the production of nuclear proteins |
| SMT202200337T1 (it) | 2012-11-26 | 2022-09-14 | Modernatx Inc | Rna modificato al livello del terminale |
| US8980864B2 (en) | 2013-03-15 | 2015-03-17 | Moderna Therapeutics, Inc. | Compositions and methods of altering cholesterol levels |
| US10023626B2 (en) | 2013-09-30 | 2018-07-17 | Modernatx, Inc. | Polynucleotides encoding immune modulating polypeptides |
| US10323076B2 (en) | 2013-10-03 | 2019-06-18 | Modernatx, Inc. | Polynucleotides encoding low density lipoprotein receptor |
| KR20170052690A (ko) * | 2014-09-17 | 2017-05-12 | 메르크 파텐트 게엠베하 | 고형암 및/또는 이의 전이 치료 방법, 그에 따른 약제, 및 고형암 및/또는 이의 전이 치료의 임상 결과 예측 방법 |
| WO2016106643A1 (zh) * | 2014-12-31 | 2016-07-07 | 深圳华大基因股份有限公司 | 检测非小细胞肺癌用药相关基因突变的引物及检测方法 |
| JP7023841B2 (ja) | 2015-10-23 | 2022-02-22 | エフ．ホフマン－ラ ロシュ アーゲー | マーカー分子に基づいて個体を化学療法により処置すべきであると同定する方法および関連する使用 |
| CN107022605B (zh) * | 2017-02-27 | 2019-10-15 | 广东医科大学 | 一种活动性肺结核的生物标志物 |
| CN107142320B (zh) * | 2017-06-16 | 2021-03-09 | 上海易毕恩基因科技有限公司 | 用于检测肝癌的基因标志物及其用途 |
| US10788484B2 (en) | 2017-06-29 | 2020-09-29 | Quanticision Diagnostics Inc. | Apparatus and method for absolute quantification of biomarkers for solid tumor diagnosis |
| CN109426776A (zh) | 2017-08-25 | 2019-03-05 | 微软技术许可有限责任公司 | 基于深度神经网络的对象检测 |
| CN109470854B (zh) * | 2017-09-08 | 2022-02-11 | 广州市丹蓝生物科技有限公司 | 肺癌诊断用蛋白芯片及试剂盒 |
| CN109470858B (zh) * | 2017-09-08 | 2022-02-15 | 广州市丹蓝生物科技有限公司 | 肺癌诊断用蛋白芯片及试剂盒 |
| JP2019086348A (ja) * | 2017-11-06 | 2019-06-06 | 公益財団法人ヒューマンサイエンス振興財団 | バイオマーカー及び血液試料中のｖｅｇｆ−ｃ濃度の測定方法 |
| JP2021506308A (ja) | 2017-12-19 | 2021-02-22 | ザ・ウイスター・インステイテユート・オブ・アナトミー・アンド・バイオロジー | 遺伝子発現プロファイルを使用して肺癌を診断するための組成物および方法 |
| US10925875B2 (en) | 2018-01-23 | 2021-02-23 | National Jewish Health | Methods of treating steroid resistant diseases and conditions |
| CN108931587B (zh) * | 2018-04-18 | 2021-09-07 | 湖州市中心医院 | 一种定量筛选nsclc的诊断生物标志物的方法 |
| RU2706116C1 (ru) * | 2018-12-26 | 2019-11-14 | Государственное бюджетное учреждение здравоохранения Московской области "Московский областной научно-исследовательский клинический институт им. М.Ф. Владимирского" (ГБУЗ МО МОНИКИ им. М.Ф. Владимирского) | Способ прогнозирования течения аденокарциномы легкого |
| GB201901439D0 (en) * | 2019-02-01 | 2019-03-27 | Univ London | Method of predicting survival rates for cancer patients |
| CN116574805A (zh) * | 2023-02-23 | 2023-08-11 | 上海交通大学医学院 | 一种预测抗pd-1免疫治疗的肺癌预后标记物及其应用 |
Family Cites Families (9)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN101111768A (zh) * | 2004-11-30 | 2008-01-23 | 维里德克斯有限责任公司 | 肺癌预后 |
| JP2008521412A (ja) * | 2004-11-30 | 2008-06-26 | ベリデックス・エルエルシー | 肺癌予後判定手段 |
| EP1980627A1 (en) * | 2007-04-13 | 2008-10-15 | Pangaea Biotech, S.A. | Method of determining a chemotherapeutic regime and survival expectancy for non small cell lung cancer based on EGFR/CSF-1/CA IX expression |
| WO2008147205A1 (en) * | 2007-06-01 | 2008-12-04 | Agendia B.V. | Prognostic gene expression signature for non small cell lung cancer patients |
| JP5583117B2 (ja) * | 2008-05-14 | 2014-09-03 | ユニバーシティー ヘルス ネットワーク | 非小細胞肺癌およびアジュバント化学療法に関する予後診断的および予測的な遺伝子シグネチャー |
| EP2321410A4 (en) * | 2008-07-16 | 2011-09-14 | Oncotherapy Science Inc | ONCOGEN ECT2 AS A THERAPEUTIC TARGET AND PROGNOSTIC INDICATOR FOR LUNG AND SOPHAGE CANCER |
| NO328852B1 (no) * | 2008-09-24 | 2010-05-31 | Moss Maritime As | Fremgangsmate og system for behandling av gass |
| WO2010063121A1 (en) * | 2008-12-04 | 2010-06-10 | University Health Network | Methods for biomarker identification and biomarker for non-small cell lung cancer |
| JP4782854B2 (ja) * | 2009-03-10 | 2011-09-28 | ナショナル ヤン−ミン ユニバーシティ | 癌患者の潜在的転移能、予後、又は全生存を予測する方法 |
-
2012
- 2012-05-24 PL PL12723210T patent/PL2714926T3/pl unknown
- 2012-05-24 PT PT127232106T patent/PT2714926E/pt unknown
- 2012-05-24 JP JP2014511892A patent/JP2014516531A/ja active Pending
- 2012-05-24 EP EP12723210.6A patent/EP2714926B1/en not_active Not-in-force
- 2012-05-24 SG SG2013079074A patent/SG194615A1/en unknown
- 2012-05-24 ES ES12723210.6T patent/ES2550192T3/es active Active
- 2012-05-24 WO PCT/EP2012/059784 patent/WO2012160177A1/en not_active Ceased
- 2012-05-24 CN CN201280025474.0A patent/CN103562409B/zh not_active Expired - Fee Related
- 2012-05-24 RU RU2013157589/10A patent/RU2013157589A/ru not_active Application Discontinuation
- 2012-05-24 US US14/119,604 patent/US20140227372A1/en not_active Abandoned
- 2012-05-24 CA CA2836844A patent/CA2836844A1/en not_active Abandoned
- 2012-05-24 BR BR112013029787A patent/BR112013029787A2/pt not_active IP Right Cessation
- 2012-05-24 KR KR1020137030738A patent/KR20140024907A/ko not_active Withdrawn
- 2012-05-24 MX MX2013013746A patent/MX340453B/es active IP Right Grant
- 2012-05-24 AU AU2012260785A patent/AU2012260785B2/en not_active Ceased
-
2013
- 2013-11-07 IL IL229319A patent/IL229319A0/en unknown
Also Published As
| Publication number | Publication date |
|---|---|
| AU2012260785B2 (en) | 2016-02-11 |
| CA2836844A1 (en) | 2012-11-29 |
| CN103562409B (zh) | 2016-04-27 |
| JP2014516531A (ja) | 2014-07-17 |
| BR112013029787A2 (pt) | 2017-01-17 |
| EP2714926A1 (en) | 2014-04-09 |
| US20140227372A1 (en) | 2014-08-14 |
| HK1193637A1 (en) | 2014-09-26 |
| CN103562409A (zh) | 2014-02-05 |
| RU2013157589A (ru) | 2015-06-27 |
| AU2012260785A1 (en) | 2013-11-14 |
| MX340453B (es) | 2016-07-08 |
| PT2714926E (pt) | 2015-11-03 |
| SG194615A1 (en) | 2013-12-30 |
| EP2714926B1 (en) | 2015-07-22 |
| WO2012160177A1 (en) | 2012-11-29 |
| IL229319A0 (en) | 2014-01-30 |
| ES2550192T3 (es) | 2015-11-05 |
| KR20140024907A (ko) | 2014-03-03 |
| MX2013013746A (es) | 2014-02-27 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| IL229319A0 (en) | Lung cancer biomarkers | |
| IL252163A0 (en) | Lung cancer biomarkers and their uses | |
| EP2718721A4 (en) | CIRCULATING BIOMARKERS FOR CANCER | |
| EP2841603A4 (en) | METHODS OF ASSESSING THE STATUS OF LUNG CANCER | |
| EP2678448A4 (en) | CIRCULATING BIOMARKERS | |
| EP2739754A4 (en) | MICRO-RNA biomarkers | |
| PL2931922T3 (pl) | Personalizowane biomarkery nowotworu | |
| GB201213567D0 (en) | Biomarkers | |
| PL2726635T3 (pl) | Multigenowy prognostyczny test na raka płuc | |
| EP2668295A4 (en) | METHODS OF DETECTING LUNG CANCER | |
| GB201120860D0 (en) | Cancer immunotherapy | |
| EP2691545A4 (en) | METHOD FOR CLASSIFYING LUNG CANCER | |
| GB2494580B (en) | Method for diagnosing lung cancer | |
| WO2012167112A9 (en) | Gastric cancer biomarkers | |
| GB201104556D0 (en) | Biomarkers | |
| EP2707721A4 (en) | BIOMARKERS PREDICTIVE FOR PROSTATE CANCER | |
| GB201210565D0 (en) | Biomarkers | |
| EP2753716A4 (en) | NEW RISK BIO MARKERS FOR LUNG CANCER | |
| GB2510539B (en) | Biomarkers of cancer | |
| IL231556A0 (en) | Biomarkers for infection of the respiratory system | |
| IL235315A0 (en) | Biomarkers for the treatment of inhibitors of the type of apoptosis inhibitors | |
| GB201113968D0 (en) | Prognostic methadology | |
| GB201004304D0 (en) | Biomarkers for prostate cancer | |
| EP2769225A4 (en) | BIOLOGICAL MARKERS PREDICTIVE FOR BREAST CANCER | |
| GB201107675D0 (en) | Prognostic biomarkers for lung diseases |